Picture of Inspiration Healthcare logo

IHC Inspiration Healthcare News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

RCS - Inspiration Health - Investor results presentation

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230922:nRSV2576Na&default-theme=true

RNS Number : 2576N  Inspiration Healthcare Group PLC  22 September 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Investor results presentation

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in class, specialist neonatal intensive care medical
devices, announces that the Company will provide a live presentation to
investors via the Investor Meet Company platform on Friday, 6 October 2023
at 11am BST.

 

The presentation will give an update on the Company and an overview of the
Group's interim results for the six months ended 31 July 2023 which will be
issued on Tuesday, 3 October 2023, as stated in the recent trading update.

 

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via the Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to
meet Inspiration Healthcare.

To register for the presentation, please use this link:

https://www.investormeetcompany.com/inspiration-healthcare-group-plc/register-investor
(https://www.investormeetcompany.com/inspiration-healthcare-group-plc/register-investor)

 

Investors who already follow Inspiration Healthcare on the Investor Meet
Company platform will automatically be invited.

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                   Tel: +44  (0)330 175 0000

 Neil Campbell, Chief Executive Officer
 Alan Olby, Chief Financial Officer

 Walbrook PR Ltd (Media and Investor Relations)  Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                                                        Mob: +44 (0) 7876 741 001
 Stephanie Cuthbert                                                                 Mob: +44 (0) 7796 794 663
 Louis Ashe-Jepson                                                                  Mob: +44 (0) 7747 515 393

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in neonatal intensive care & operating theatres. The Company
provides high quality innovative products to patients around the world which
help to improve patient outcomes and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days
of life to help premature and sick babies; helping resuscitation and
stabilisation in the first moments of life through to preventing brain damage
and both invasive and non-invasive respiratory support in terms of capital
equipment and disposable medical devices. Additionally, the Company has its
own range of products for maintaining normothermia pre, during and
post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer,
manufacturer and supplier of single use respiratory products and sterile
medical consumables and S.L.E., a leading designer, manufacturer and global
provider of neonatal ventilation products.  The Group generates approximately
58% of its revenues from export markets and more than half of its revenues
come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a
distribution network, Inspiration Healthcare's success has been built on
continuous innovation, excellent customer service and an inherent commitment
to improving patient outcomes, working in close collaboration with key opinion
leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded
and complementary products from third parties, with an additional range of
home healthcare products.  This is supported by Technical Support for planned
preventative maintenance and emergency assistance.

 

The Group operates from various sites in the UK for R&D, Marketing and
operations with manufacturing based in Croydon (south London) and Hailsham
(East Sussex).  The Group's Head Office is located in Crawley, a short
distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPPUPUBUPWGWG

Recent news on Inspiration Healthcare

See all news